{"schema_version":"secwatch.filing_event.v1","accession":"0001516551-23-000018","form_type":"8-K","ticker":"SKYE","cik":"0001516551","company_name":"Skye Bioscience, Inc.","filed_at":"2023-02-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.350140+00:00","generated_at":"2026-06-19T11:12:50.599740+00:00","sec_items":["1.01","2.01","8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Skye Bioscience closes sale of Verdélite Sciences for $9.48M; receives $5.60M cash at closing","bullets":["Sold wholly owned subsidiary Verdélite Sciences and 88k sq ft cannabis facility in St-Eustache, Quebec to C3 Souvenir Holding.","Cash proceeds of $5.60M received on Feb 10, 2023; total deal value $9.48M with deferred payments through 2026.","Deferred payments: $0.12M by June 2023, $0.37M in 5 monthly installments starting Dec 2023, plus $2.80M in three equal anniversary payments.","CEO states the closing payment extends operating runway and supports Phase 2 trial for SBI-100 OE (glaucoma drug).","C3 acquires Emerald's Souvenir brand; deal brokered by Hyde Advisory and AMK Advisory Services."],"urls":{"canonical":"https://secwatch.observer/filing/0001516551-23-000018","json":"https://secwatch.observer/filing/0001516551-23-000018.json","markdown":"https://secwatch.observer/filing/0001516551-23-000018.md","text":"https://secwatch.observer/filing/0001516551-23-000018.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1516551/000151655123000018/0001516551-23-000018-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1516551/000151655123000018/skye-20230209.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T11:12:50.599740+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"efda8d24ee2a2e4cc221c5fa6236153596856507","claim":"Skye Bioscience, Inc. completed a disposition involving C3 Souvenir Holding, Inc. for approximately USD$9,478,000 (closed 2023-02-09).","evidence_excerpt":"acquire all of the outstanding shares of Verdélite Sciences, Inc., the holder of EHT's most significant real estate asset, for an aggregate purchase price of approximately USD$9,478,000, subject to certain adjustments. To facilitate the closing of the transactions contemplated by the Verdélite SPA, on February 9, 2023, EHT, the Purchaser and certain other related","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1516551/000151655123000018/0001516551-23-000018-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"disposition"},{"label":"Counterparty","value":"C3 Souvenir Holding, Inc."},{"label":"Consideration","value":"approximately USD$9,478,000"},{"label":"Closing","value":"2023-02-09"}],"fact_type":"ma_transaction"},{"claim_id":"aef2181d96ed29aaed9c0f4260d05a23e0184e1f","claim":"Skye Bioscience, Inc. amended Verdélite SPA with C3 Souvenir Holding, Inc. and certain other related parties valued at approximately USD$9,478,000 (effective 2023-02-09).","evidence_excerpt":"on February 9, 2023, EHT, the Purchaser and certain other related parties entered into a second amendment to the Verdélite SPA (the \"Second Amendment\")","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1516551/000151655123000018/0001516551-23-000018-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"C3 Souvenir Holding, Inc. and certain other related parties"},{"label":"Value","value":"approximately USD$9,478,000"},{"label":"Effective","value":"2023-02-09"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}